Annual Shareholders Equity
$349.10 M
-$11.58 M-3.21%
December 31, 2023
Summary
- As of February 8, 2025, EDIT annual stockholders equity is $349.10 million, with the most recent change of -$11.58 million (-3.21%) on December 31, 2023.
- During the last 3 years, EDIT annual shareholders equity has fallen by -$44.49 million (-11.30%).
- EDIT annual shareholders equity is now -36.95% below its all-time high of $553.64 million, reached on December 31, 2021.
Performance
EDIT Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$175.63 M
-$56.38 M-24.30%
September 30, 2024
Summary
- As of February 8, 2025, EDIT quarterly stockholders equity is $175.63 million, with the most recent change of -$56.38 million (-24.30%) on September 30, 2024.
- Over the past year, EDIT quarterly shareholders equity has dropped by -$184.83 million (-51.28%).
- EDIT quarterly shareholders equity is now -72.47% below its all-time high of $638.00 million, reached on March 31, 2021.
Performance
EDIT Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
EDIT Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.2% | -51.3% |
| 3 y3 years | -11.3% | -70.1% |
| 5 y5 years | +47.8% | -16.4% |
EDIT Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -37.0% | at low | -68.3% | at low |
| 5 y | 5-year | -37.0% | +33.0% | -72.5% | at low |
| alltime | all time | -37.0% | +520.0% | -72.5% | +311.3% |
Editas Medicine Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $175.63 M(-24.3%) |
| Jun 2024 | - | $232.01 M(-21.2%) |
| Mar 2024 | - | $294.40 M(-15.7%) |
| Dec 2023 | $349.10 M(-3.2%) | $349.10 M(-3.2%) |
| Sep 2023 | - | $360.46 M(-9.9%) |
| Jun 2023 | - | $399.92 M(+26.0%) |
| Mar 2023 | - | $317.47 M(-12.0%) |
| Dec 2022 | $360.68 M(-34.9%) | $360.68 M(-13.0%) |
| Sep 2022 | - | $414.75 M(-10.9%) |
| Jun 2022 | - | $465.41 M(-9.2%) |
| Mar 2022 | - | $512.76 M(-7.4%) |
| Dec 2021 | $553.64 M(+40.7%) | $553.64 M(-5.6%) |
| Sep 2021 | - | $586.79 M(-4.3%) |
| Jun 2021 | - | $613.36 M(-3.9%) |
| Mar 2021 | - | $638.00 M(+62.1%) |
| Dec 2020 | $393.59 M(+50.0%) | $393.59 M(-10.8%) |
| Sep 2020 | - | $441.15 M(+3.4%) |
| Jun 2020 | - | $426.77 M(+81.9%) |
| Mar 2020 | - | $234.57 M(-10.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $262.44 M(+11.1%) | $262.44 M(+25.0%) |
| Sep 2019 | - | $209.99 M(+8.8%) |
| Jun 2019 | - | $193.06 M(-11.1%) |
| Mar 2019 | - | $217.16 M(-8.0%) |
| Dec 2018 | $236.16 M(+13.5%) | $236.16 M(+5.2%) |
| Sep 2018 | - | $224.45 M(-3.0%) |
| Jun 2018 | - | $231.33 M(-6.5%) |
| Mar 2018 | - | $247.51 M(+19.0%) |
| Dec 2017 | $208.08 M(+54.6%) | $208.08 M(+17.0%) |
| Sep 2017 | - | $177.79 M(-3.9%) |
| Jun 2017 | - | $185.00 M(-10.4%) |
| Mar 2017 | - | $206.46 M(+53.4%) |
| Dec 2016 | $134.61 M(-262.0%) | $134.61 M(-20.9%) |
| Sep 2016 | - | $170.18 M(-9.2%) |
| Jun 2016 | - | $187.33 M(-7.0%) |
| Mar 2016 | - | $201.36 M(-342.3%) |
| Dec 2015 | -$83.11 M(+443.5%) | -$83.11 M(-165.1%) |
| Sep 2015 | - | $127.62 M(-934.5%) |
| Dec 2014 | -$15.29 M(+767.4%) | -$15.29 M |
| Dec 2013 | -$1.76 M | - |
FAQ
- What is Editas Medicine annual stockholders equity?
- What is the all time high annual shareholders equity for Editas Medicine?
- What is Editas Medicine annual shareholders equity year-on-year change?
- What is Editas Medicine quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Editas Medicine?
- What is Editas Medicine quarterly shareholders equity year-on-year change?
What is Editas Medicine annual stockholders equity?
The current annual shareholders equity of EDIT is $349.10 M
What is the all time high annual shareholders equity for Editas Medicine?
Editas Medicine all-time high annual stockholders equity is $553.64 M
What is Editas Medicine annual shareholders equity year-on-year change?
Over the past year, EDIT annual stockholders equity has changed by -$11.58 M (-3.21%)
What is Editas Medicine quarterly stockholders equity?
The current quarterly shareholders equity of EDIT is $175.63 M
What is the all time high quarterly shareholders equity for Editas Medicine?
Editas Medicine all-time high quarterly stockholders equity is $638.00 M
What is Editas Medicine quarterly shareholders equity year-on-year change?
Over the past year, EDIT quarterly stockholders equity has changed by -$184.83 M (-51.28%)